Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Incyte Corporation
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Merck KGaA, Darmstadt, Germany
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company